AzTrials
AzTrials

Multiple SclerosisMS-MI-SMNCT07710742

Effects Of Motor Imagery and Sensorimotor Training

A study testing Motor imagery, Sensorimotor Training and Conventional therapy in people with Multiple Sclerosis, run by Uludag University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Many types of pain can occur in Multiple Sclerosis (MS), one of the most common types is neuropathic pain. Neuropathic pain is directly related to the disease's demyelination process and is associated with dysesthetic pain, allodynia, hyperalgesia. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Multiple Sclerosis
What is being tested?
Motor imagery, Sensorimotor Training and Conventional therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteTurkey (Türkiye)
Study dates
9 Jul 2026to 9 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 18-45 years of age,
  • Having received a definitive MS diagnosis according to the 2024 McDonald criteria,
  • Not having had a relapse in the past 3 months,
  • Having an EDSS score of ≤ 6.00,
  • Presence of neuropathic pain in the lower extremities that has persisted for at least 3 months or is recurrent,
  • Confirmation of the presence of neuropathic pain by a neurologist,

Who cannot join

  • The presence of any other orthopedic or neurological condition that could interfere with participation in the study,
  • A level of spasticity in the lower extremities of ≥ 1+ on the Modified Ashworth Scale,
  • The presence of any hearing, vision, or cognitive impairment that could interfere with the assessments,
  • Receiving additional treatment beyond routine medication,
  • Participating in another physical therapy program during the study period,
  • Having conditions unrelated to MS that cause pain.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Bursa Uludag University

    Bursa, Nilüfer, 16059

    Şeyma Dilek, +90(224)2955364, seymadilek@uludag.edu.tr

    şeyma DİLEK

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Effects of Motor Imagery and Sensorimotor Training on Neuropathic Pain, Proprioception, Balance, and Reaction Time in Multiple Sclerosis

Many types of pain can occur in Multiple Sclerosis (MS), one of the most common types is neuropathic pain. Neuropathic pain is directly related to the disease's demyelination process and is associated with dysesthetic pain, allodynia, hyperalgesia. For neuropathic pain in MS, there are numerous physical therapy and rehabilitation interventions focused on proprioception, balance reaction time management. Loss of proprioception is commonly observed in MS, this loss results from the demyelination of the central somatosensory pathways. Proprioception-the ability to perceive the position of the body and limbs relative to the environment-is also related to balance performance. Balance problems can be detected in the early stages of the disease, even if the patient has no disability. Another effect of MS is observed in reaction time. In MS, which is characterized by demyelination, axonal damage, a slowing of nerve conduction velocity leads to a decrease in information processing speed, resulting in prolonged reaction times. Neuromuscular training models designed to train the Central Nervous System (CNS) can be used to address these effects.Motor Imagery (MI) is one of the neuromuscular training models.

Imagery can be defined as the use of all one's senses to create a mental image of an activity. MI is referred to as a brain-training method and utilizes the neuromatrix theory to inhibit pain. MI training aims to retrain the neural networks that activate the neuromatrix so that they become less sensitive to stimuli that would not normally cause pain. Lateralization is a method used in conjunction with MI to distinguish between the right and left sides of the painful area. The imagery phase involves visualizing the positions and movements of the painful areas. MI is a neuromuscular training model, and another neuromuscular training method is Sensorimotor (SM) training.

Read more

It is known that SM, which applies repetitive sensorimotor stimulation, passively improves sensorimotor performance. Known as perceptual learning, this approach involves simple exposure to SM stimulation for several hours. While the term "perceptual" encompasses various senses, including sight and hearing, the term "sensorimotor training" is used here specifically to refer to methods focused on SM stimulation. SM training typically does not require participants to actively focus on external stimuli, which makes it easily applicable in neuro-rehabilitation settings. It does not focus solely on increasing muscle strength in a specific area; rather, it aims to improve movement quality and patterns by training the CNS. This training model, which emphasizes the importance of sensory input in developing motor skills, plays an effective role in improving balance, enhancing functionality, and reducing pain. Studies demonstrating the effectiveness of SM interventions in MS are available. The literature shows that both MI and SM have effects on neuropathic pain, proprioception, balance, and reaction time in individuals with MS. These two methods involve different neurophysiological mechanisms. For example, MI sends a "top-down" message to the brain. It first uses laterality (right/left distinction), then imagery, and prepares the brain for movement. SM, however, sends a "bottom-up" message to the brain. It focuses primarily on sensory input. Furthermore, while MI is an approach that aims to activate central motor networks without peripheral afferent input, SM supports central motor control processes by enhancing peripheral sensory input. In addition to these differences, it is known that both methods actually train CNS.The literature shows that both MI and SM have effects on neuropathic pain, proprioception, balance, and reaction time in individuals with MS. These two methods involve different neurophysiological mechanisms. For example, MI sends a "top-down" message to the brain. It first uses laterality (right/left distinction), then imagery, and prepares the brain for movement. SM, however, sends a "bottom-up" message to the brain. It focuses primarily on sensory input. Furthermore, while MI is an approach that aims to activate central motor networks without peripheral afferent input, SM supports central motor control processes by enhancing peripheral sensory input. There are only a few studies comparing these two methods.No studies have been found in the literature that compare these two methods in patients with MS and examine their effects.

The aim of our study is to examine the effects of MI and SM training administered to individuals with MS. Motor control in patients with MS is a process resulting from the interaction of central and peripheral mechanisms. For this reason, it is believed that comparing the relative effects of central-focused (MI) and peripheral-focused (SM) approaches could contribute to the development of rehabilitation interventions.

Read the detailed description

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, progressive neurological disease that affects the Central Nervous System (CNS). Among the most common problems in MS are neuropathic pain, loss of proprioception, and balance issues. Many types of pain can be observed in MS, and neuropathic pain is one of the most common types. Neuropathic pain is directly related to the disease's demyelination process and is associated with dysesthetic pain, allodynia, and hyperalgesia. For neuropathic pain in MS, there are numerous physical therapy and rehabilitation interventions focused on proprioception, balance, and reaction time management. Loss of proprioception is commonly observed in MS, and this loss results from the demyelination of the central somatosensory pathways. Loss of proprioception negatively affects the patient's independence in activities of daily living. Proprioception-the ability to perceive the position of the body and limbs relative to the environment-is also related to balance performance. Balance problems are observed in 50-80% of people with MS. Balance problems emerge throughout the course of MS and, while they may worsen with recurrent relapses, they can also occur between relapses. Balance problems can be detected in the early stages of the disease, even in the absence of any disability. Another effect of MS is observed in reaction time. In MS, which is characterized in particular by demyelination and axonal damage, a slowing of nerve conduction velocity leads to a decrease in information processing speed, resulting in prolonged reaction time. Studies have shown that reaction time is significantly longer in people with MS compared to healthy individuals. Neuromuscular training models designed to train the CNS can be used to treat these conditions. Motor Imagery (MI) is one such neuromuscular training model.

Imagery can be defined as the use of all the senses to create a mental image of an activity. MI is referred to as a brain training method and utilizes the neuromatrix theory to inhibit pain. MI training aims to retrain the neural networks that activate the neuromatrix so that they become less sensitive to stimuli that would not normally cause pain. Lateralization is a method used in conjunction with MI to distinguish between the right and left sides of the painful area. The imagery phase is defined as visualizing the positions and movements of the painful areas. A study examining the effects of telerehabilitation-based MI training on pain and related factors in individuals with MS included 32 participants with MS. Two groups were formed-a treatment group and a control group-and the treatment group received MI training via telerehabilitation for 8 weeks. The outcome measures included pain, motor imagery ability, cognitive functions, fatigue, quality of life, sleep quality, daytime sleepiness, and levels of depression and anxiety. The results of the study showed a significant reduction in the treatment group in overall pain intensity over the last two and seven days, in pain intensity in areas other than the elbow region over the last seven days, and in fatigue and depression levels, while there was an increase in MI ability, quality of life, and scores for processing speed and visual memory in cognitive functions. Another study examined the physical, cognitive, and psychosocial effects of telerehabilitation-based MI training in individuals with MS. A group of MS patients and a healthy control group were formed, and the MS patients underwent 8 weeks of MI training. The results of the study showed significant improvements in the intervention group in dynamic balance during walking, walking speed, perceived walking ability, balance confidence, most cognitive functions, fatigue, anxiety, depression, and quality of life. When these two studies are examined, it is possible to conclude that MI has a positive effect on individuals with MS across multiple parameters. MI is a neuromuscular training model, and another neuromuscular training method is Sensorimotor (SM) training.It is known that SM, which applies repetitive sensorimotor stimulation, passively enhances sensorimotor performance. Known as perceptual learning, this approach involves simple exposure to SM stimulation for several hours. While the term "perceptual" encompasses various senses, including sight and hearing, the term "sensorimotor training" is used here specifically to refer to methods focused on SM stimulation. SM training typically does not require participants to actively focus on external stimuli, making it easily applicable in neuro-rehabilitation settings. It does not focus solely on increasing muscle strength in a specific region but aims to improve movement quality and patterns by training CNS. This training model, which emphasizes the importance of sensation in developing motor skills, plays an effective role in improving balance, enhancing functionality, and reducing pain. Studies demonstrating the effectiveness of SM interventions in MS are available. A randomized controlled trial conducted with MS patients, a robot-assisted intervention and an SM training intervention were applied to improve upper extremity motor function. Forty-two MS patients were divided into two groups and received treatment twice a week for four weeks. The study found that the SM intervention was effective in improving upper extremity motor function. In another study, the effects of SM balance training on balance disorders, perceived balance confidence, quality of life, fatigue, fall frequency, and sensory integration processing were compared with those of traditional rehabilitation in 80 patients with MS. Patients were assessed by a blind evaluator before treatment, after treatment, and one month after treatment using the Berg Balance Scale (BBS), the Activity-Specific Balance Confidence Scale (ABC), the Multiple Sclerosis Quality of Life-54, the Fatigue Severity Scale (FSS), the number of falls, and the Sensory Organization Test (SOT). The study found that SM is effective in improving balance disorders in patients with MS. The literature shows that both MI and SM have effects on neuropathic pain, proprioception, balance, and reaction time in individuals with MS. These two methods involve different neurophysiological mechanisms. For example, MI sends a "top-down" message to the brain. It first uses laterality (right/left distinction), then imagery, and prepares the brain for movement. SM, however, sends a "bottom-up" message to the brain. It focuses primarily on sensory input. Furthermore, while MI is an approach that aims to activate central motor networks without peripheral afferent input, SM supports central motor control processes by enhancing peripheral sensory input.There are only a few studies comparing these two methods. In a study conducted on individuals with knee osteoarthritis, three groups were identified: one group received SM, one group received MI, and the other group received conventional treatment. As a result of the intervention, which was administered twice a week for a total of 6 weeks, it was concluded that MI and SM exercises significantly improved static and dynamic balance, thereby reducing the risk of falls, and-particularly during early rehabilitation-promoted proprioceptive development at small angles (20°). No studies have been found in the literature that compare these two methods in patients with MS and examine their effects.

The aim of our study is to examine the effects of MI and SM training in individuals with MS. Motor control in patients with MS is a process resulting from the interaction of central and peripheral mechanisms. For this reason, it is believed that comparing the relative effects of central-focused (MI) and peripheral-focused (SM) approaches could contribute to the development of rehabilitation interventions.

Being tested
Motor imagery, Sensorimotor Training, Conventional therapy
Keywords
Multiple sclerosis, Proprioception, Motor Imagery, Sensorimotor training, Balance, Neuropathic Pain, Reaction Time
Medical subject headings
Multiple Sclerosis, Neuralgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor imageryBehavioural

    The patient will participate in motor imagery training two days a week for eight weeks.

  • Sensorimotor TrainingBehavioural

    The patient will participate in sensorimotor training two days a week for eight weeks.

  • Conventional therapyBehavioural

    The patient will participate in conventional therapy two days a week for eight weeks.

Study groups in NCT07710742
Study groupRoleWhat they receive
Motor imagery GroupExperimentalThe patient will participate in motor imagery training two days a week for eight weeks.
Receives: Behavioral: Motor imagery
Sensorimotor Training GroupExperimentalThe patient will participate in sensorimotor training two days a week for eight weeks.
Receives: Behavioral: Sensorimotor Training
Conventional Therapy GroupActive comparatorThe patient will participate in conventional therapy two days a week for eight weeks.
Receives: Behavioral: Conventional therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of Neuropathic Pain

    Algometer will be used. Each patient will be taught how to distinguish between tactile and painful stimuli. PPT will be recorded as the amount of pressure required to elicit a sensation of pain distinct from pressure or discomfort. Patients will be asked to say "stop" as soon as they feel a distinct sensation of pain; at that point, the algometer's pressure will be released immediately and the piston will be retracted by the evaluator.

    Measured: Registration to the end of the 12th week

  2. Assessment of Neuropathic Pain

    The Leeds Neuropathic Symptoms and Signs Assessment (S-LANSS) will be used. The S-LANSS consists of a 5-item questionnaire regarding pain symptoms and a 2-item clinical symptom scale that includes self-administered sensory tests for the presence of allodynia and reduced sensitivity to needle pricks. Responses to each item are binary (yes or no), and each item is weighted differently based on the odds ratio of a positive response to that item, in order to predict whether the pain is primarily neuropathic. Possible scores range from 0 to 24, and a score of 12 or higher suggests neuropathic pain.

    Measured: From the registration stage until the end of the 12th week

  3. Reaction Time Assesments

    Kinovea software will be used. The feature that allows the video to continue without disrupting the flow of time while slowing it down will be utilized. A video recording capturing the reaction to taking a step will be made and uploaded to the Kinovea software.

    Measured: From the registration stage until the end of the 12th week.

  4. Balance Assessment

    HUR SmartBalance BTG4 balance platform will be used.Postural stability and stability limits will be measured and recorded.

    Measured: From the registration stage until the end of the 12th week.

  5. Joint Position Sense

    Digital Goniometer will be used. For the lower extremity, the following angles will be measured and recorded: 60 degrees of hip flexion; 45 degrees of knee flexion; and 15 degrees of ankle dorsiflexion.

    Measured: From the registration stage until the end of the 12th week.

Secondary outcomes (8)
  1. Motor Imagery Ability Assessment

    The Kinesthetic and Visual Imagery Questionnaire (KVIQ) kinesthetic score will be used. During the assessment, participants are first instructed to visualize the requested movement and are then asked to actually perform it. After physically performing the movement, participants are asked to visualize themselves performing the same movement as if they were actually doing it. Participants rate the quality of the visual image in their imagination on a scale of 1 to 5, where 1 means "no image" and 5 means "as clear as the real thing.

    Measured: From the registration stage until the end of the 12th week

  2. Mental Chronometer

    The mental chronometer will be administered in conjunction with the Timed Up and Go test.Participants will be asked to imagine walking at their normal pace from the chair to a wooden block 3 meters away, walking around the wooden block, walking back to the chair, sitting down, and letting the researcher know when they have sat down. The time between the researcher's "start" command and the participant's statement "I'm seated" will be recorded by the researcher using a stopwatch. The temporal alignment between the actual and imagined movements will be calculated as the delta time using the formula: "(actual movement - imagined movement) / [(actual movement + imagined movement) / 2] × 100."

    Measured: From registration up to the 12th week

  3. Cognitive Functions Assessment

    The Brief International Cognitive Assessment Battery (BICAMS) will be used.The scale consists of three subscales: processing speed, as assessed by the Symbol Number Modalities Test; verbal memory, as assessed by the California Verbal Learning Test-II; and visual memory, as assessed by the Short Visual-Spatial Memory Test.

    Measured: From the registration stage until the end of the 12th week

  4. Fatigue Assessment

    The Fatigue Severity Scale will be used.The scale's questions are scored using a 7-point Likert scale ranging from "strongly disagree (1)" to "strongly agree (7)." The scale score is calculated as the average of the responses to the questions asked.

    Measured: From the registration stage until the end of the 12th week

  5. MS Symptom Severity Assessment

    SymptoMScreen will be used.It includes 12 areas commonly affected by MS. These are walking, hand function, stiffness, spasticity, pain, sensory deficits, urinary function, vision, fatigue, dizziness, cognitive function, anxiety, and depression. For each item, patients indicate the severity of symptoms-reflecting the impact on activities of daily living-using a seven-point Likert-type scale ranging from 0 (not affected) to 6 (completely restricted/unable to perform most daily activities). Each domain is scored on a Likert scale ranging from 0 to 6. The total scale score ranges from 0 to 72 points.

    Measured: From the registration stage until the end of the 12th week

  6. Anxiety and Depression Assesments

    Hospital Anxiety and Depression Scale will be used.The scale consists of 14 items. The items on the scale are rated using a 4-point Likert scale and scored on a scale of 0 to 3. The total scores for the scale's anxiety and depression subscales range from 0 to 21.

    Measured: From the registration stage until the end of the 12th week

  7. Walk Assesments

    Timed 25-Foot Walk Test will be used.The patient will be instructed to walk as quickly and safely as possible (i.e., at maximum walking speed) along a 25-foot or 7.62-meter straight course. The course will have no turns, and the patient will begin by standing upright and motionless. An assistive device may be used. The patient will walk the 25-foot course twice; the average time in seconds from the two consecutive trials will be recorded.

    Measured: From the registration stage until the end of the 12th week

  8. Backward Walking Assesments

    3-Meter Backward Walking Test will be used.Patients will be asked to align their heels with the marked spot. They will be instructed to walk backward as quickly as possible upon hearing the command "Walk" and to stop when they reach 3 meters. The time taken to complete this will be recorded in seconds.

    Measured: From the registration stage until the end of the 12th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2026
  2. Study start9 Jul 2026 (estimated)
  3. Primary completion9 Jul 2027 (estimated)
  4. Study completion9 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
MS patients included in the study will be assigned to intervention groups using a randomization method. Three groups will be formed using a computer-based e-randomization program (https://www.randomizer.org/) for the randomization process. The first group will receive Motor Imagery Training twice a week for 8 weeks. The second group will receive Sensorimotor Training twice a week for 8 weeks. The third group will receive Conventional Training twice a week for 8 weeks. Assessments will be conducted in person by the same physical therapist. All assessments will be repeated before the intervention, after the intervention, and at week 12.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
51 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07710742
Sponsor's protocol ID
2026/297/11-1
Acronym
MS-MI-SM
Status last verified
Jul 2026
First submitted
2 Jul 2026
Last updated
17 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: To protect participant confidentiality and privacy, study results will be reported only in aggregate form.

Questions about this trial

What is this clinical trial studying?

A study testing Motor imagery, Sensorimotor Training and Conventional therapy in people with Multiple Sclerosis, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Şeyma Dilek (+90(224)2955364, seymadilek@uludag.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of Neuropathic Pain (time frame: Registration to the end of the 12th week). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in